It seems we can’t find what you’re looking for. Perhaps searching can help.
1933 - 2017
Odette Cancer Centre – A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE 641)